<DOC>
	<DOCNO>NCT00811577</DOCNO>
	<brief_summary>The purpose study determine safety AZX100 Drug Product determine whether effective prevent reduce scar make trocars follow arthroscopic shoulder surgery .</brief_summary>
	<brief_title>A Phase 2a Study Evaluate Safety Efficacy AZX100 Trocar Sites Arthroscopic Shoulder Surgery Patients</brief_title>
	<detailed_description />
	<criteria>Scheduled arthroscopic shoulder surgery result least 3 trocar site Healthy male nonpregnant female 1875 year old Nondiabetic Body Mass Index 1835 No clinically significant abnormal value blood test Nonsmoker previous 6 month History acute chronic disease Cancer within previous 5 year , except remove skin cancer Hypersensitivity reaction Allergy general anesthesia , lidocaine , epinephrine Current skin disorder folliculitis acne On therapy steroid On therapy drug affect collagen synthesis Positive HIV hepatitis Positive urine test nicotine Positive blood test antiAZX100 antibody Participated another clinical study within 60 day enrollment Gave blood within 7 day dose Gave plasma within 3 day dose Tattoo shoulder area Applied prescribe counter agent shoulder within 14 day dose , intend use scar improve product Visited tan salon within 14 day dose History drug addiction excessive use alcohol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>AZX100</keyword>
	<keyword>Patient Observer Scar Assessment Scale</keyword>
	<keyword>POSAS</keyword>
	<keyword>Visual Analog Scale</keyword>
	<keyword>VAS</keyword>
	<keyword>Trocar</keyword>
	<keyword>Scarring</keyword>
	<keyword>Scar reduction</keyword>
	<keyword>Scar prevention</keyword>
</DOC>